IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences Profit Margin (Quarterly) : -1.27K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.27K% |
| March 31, 2026 | -1.50K% |
| December 31, 2025 | -765.7% |
| September 30, 2025 | 57.37% |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | -1.86K% |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | -865.5% |
| September 30, 2023 | -341.4% |
| Date | Value |
|---|---|
| June 30, 2023 | -788.0% |
| March 31, 2023 | -300.0% |
| December 31, 2022 | -601.7% |
| September 30, 2022 | 5.44% |
| June 30, 2022 | -377.0% |
| March 31, 2022 | -123.4% |
| December 31, 2021 | -614.6% |
| September 30, 2021 | -129.0% |
| June 30, 2021 | -125.0% |
| March 31, 2021 | -124.5% |
| December 31, 2020 | -48.58% |
| September 30, 2020 | -54.93% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 45.37% |
| Xencor, Inc. | -42.42% |
| BioMarin Pharmaceutical, Inc. | 4.49% |
| MediciNova, Inc. | -504.8% |
| Viking Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.79% |
| Return on Assets | -15.42% |
| Return on Invested Capital | -16.36% |
| Gross Profit Margin (Quarterly) | 87.21% |
| Operating Margin (Quarterly) | -1.38K% |
| Return on Net Operating Assets | -487.7% |